VA Office of Research and Development
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, VA Office of Research and Development sits in the top decile of US sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count).
VA Office of Research and Development: 1,668 sponsored US clinical trials, 291 recruiting.
VA Office of Research and Development sponsors 1,668 registered US clinical trials on ClinicalTrials.gov, 291 of them currently recruiting, and 1,108 completed. 124 of these trials are in Phase 3-4 (later-stage) and 236 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PTSD, with 28 trials.
Top-decile sponsor footprint
VA Office of Research and Development ranks in the top decile of sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,668 total, page 24 of 34
Treatment of Trauma-Related Anger in OEF/OIF/OND Veterans
NCT02157779
Mobile Tablet Education to Advance Caregiver Health
NCT03417219
Cognitive Rehabilitation for Gulf War Illness
NCT02161133
Can Service Dogs Improve Activity and Quality of Life in Veterans With PTSD?
NCT02039843
Jump Start Shared Medical Appointments for Diabetes With Weight Management
NCT01973972
Treatment of Prolonged Grief Disorder in Combat Veterans
NCT02283333
Loving-Kindness Meditation for PTSD
NCT01962714
Smart Phone Application for Postconcussion Symptom Reduction
NCT02501642
Wide Frequency Band Test of Hearing in Veterans
NCT02019888
Telemedicine Intervention to Improve Cognitive Function
NCT02248649
Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment
NCT02155946
Improving Patient-centered Care Using an Inventory
NCT01843803
Tobacco Treatment as Augmentation for Cognitive Processing Therapy for PTSD
NCT02012452
Nutrition and Aerobic Exercise in Chronic Stroke
NCT02043574
Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders
NCT01947647
Insulin Resistance and Reward
NCT02241603
Meditation in Veterans With PTSD and Mild TBI
NCT02280304
Informal Caregivers ANSWERS-VA
NCT02398409
CBT-I for Cannabis Use
NCT02102230
FES Rowing for Skeletal Health After SCI
NCT02008149
Improving Sleep in Veterans and Their CGs
NCT02057068
Comparative Effectiveness Research in Veterans With PTSD
NCT01928732
Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2
NCT02278562
Atomoxetine in Veterans With Comorbid ADHD/PTSD
NCT02287038
Effect of Probenecid on Synovial Fluid ATP Levels in CPPD
NCT02243631
Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI
NCT02057081
Metformin in Kidney Disease
NCT02252081
Internet and Telephone Support Intervention for Stroke Caregivers
NCT04348851
Biomarker Guided Therapies in Stage A/B Heart Failure
NCT02230891
rTMS to Improve Cognitive Function in TBI
NCT02152540
TeleMonitoring to Improve Substance Use Disorder Treatment After Detoxification
NCT02269787
Will Veterans Engage in Prevention After HRA-guided Shared Decision Making?
NCT01828567
Sustainability of Pulmonary Rehab Gains
NCT02241733
Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers
NCT02245308
Predictors of Decompressive Laminectomy Outcomes
NCT02215551
Improving Anticoagulation Control in VISN 1
NCT01653405
Building an Optimal Hand Hygiene Bundle
NCT02223455
Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation
NCT02005445
Service and Health During the Iraq and Afghanistan Era
NCT01987401
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
NCT01771965
Strength Training and Endurance Exercise for LIFE
NCT02101060
Phosphate Lowering in CKD Trial
NCT02209636
Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
NCT02148029
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
NCT01855399
Behavioral Activation for Smoking Cessation in PTSD
NCT01995123
Insomnia Treatment for Women Veterans
NCT02076165
Contribution of Endothelin-1 to Exercise Intolerance in Heart Failure
NCT02124824
Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis
NCT01981356
Randomized Controlled Trial of Group Prevention Coaching
NCT01838226
Neurobiological and Psychological Benefits of Exercise in Chronic Pain and PTSD
NCT03283163
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 89 |
| Phase 2 | 147 |
| Phase 3 | 55 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the VA Office of Research and Development pipeline
291 recruiting of 1,668 indexed (17% open); 1,108 completed (66%).
Phase mix: 124 late (III/IV) vs 236 early (I/II) (early-phase heavy).
Top condition: PTSD (28 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.